GLP1RAs can be effective for the treatment of obstructive sleep apnea, a condition associated with elevated white matter hyperintensity burden, microstructural damage, and cognitive impairment [37]
Tirzepatide's combination of GLP-1 and GIP receptor agonism achieved approximately 20% weight loss in clinical trials, establishing dual agonism as superior to single-target approaches [15]
This study assessed treatment persistence and adherence to semaglutide QW versus dulaglutide, liraglutide, or exenatide QW in a real-world setting
TRAb, thyrotropin receptor antibody
Cng thc c o kt hp glutathione vi cc dng cht vitamin, niacinamide, citron, acid salicylic
This blend of native bacterial strains is designed to have activity throughout the whole GI tract